A proof of concept study to detect the eye biomarkers in opioid-dependent chronic pain sufferers using an opioid tapering digital health application

eCovery0 sites6 target enrollmentDecember 15, 2021

Overview

No summary available.

Registry

who.int

Start Date

December 15, 2021

End Date

June 21, 2023

Last Updated

2 years ago

Study Type

Interventional

Sex

All

Sponsor

eCovery

•1\.Age over 18 years.
•2\.Male, or female. Women of childbearing age can be included
•3\.Must be on an oral morphine equivalent of more than 50mg for more than 3 months.
•4\.Patient must be deemed by the treating physician able to give informed consent.
•5\.The patient must be deemed able, physically and psychologically, to cooperate with the study.
•6\.Any prescribed opioids.

•1\.Pregnant.
•2\.Current substance misuse disorder. Patients on methadone and high dose buprenorphine (eg Suboxone) will be excluded. This is as the eCovery digital health application is not designed to help patients taking opioid substitution therapy for severe opioid use disorder.
•3\.Significant mental health disorder.
•4\.Do not have a mobile phone, or internet access that can use the eCovery application.
•5\.Do not have basic English speaking ability, as the eCovery application’s education is in English.
•6\.Do not wish to taper their opioids.
•7\.Any medical condition that would make tapering of opioids not possible at that stage.